What is Idexx Laboratories's other commercial liabilities?

Idexx Laboratories (IDXX) reported other commercial liabilities of $453.55M in Q1 2026.

How has Idexx Laboratories's other commercial liabilities changed year-over-year?

Idexx Laboratories's other commercial liabilities decreased by 7.6% year-over-year, from $490.69M to $453.55M.

What is the long-term trend for Idexx Laboratories's other commercial liabilities?

Over 5 years (2020 to 2025), Idexx Laboratories's other commercial liabilities has grown at a 5.0% compound annual growth rate (CAGR), from $415.65M to $530.15M.

Idexx Laboratories IDXX Other Commercial Liabilities

Other Commercial Liabilities at other companies

ZoetisZTS

——

DanaherDHR

——

RevvityRVTY

——

VeracyteVCYT

——

Exagen Inc.XGN

——

Mesa LaboratoriesMLAB

——

Other financials

Income statement

See full

Revenue$1.1B+14.3%

Gross profit$722.7M+15.9%

Operating income$362.6M+14.5%

Net income$278.4M+14.7%

EPS (diluted)$3.47+17.2%

Balance sheet

See full

Cash & equivalents$200.5M+22.3%

Total debt$575.5M-22.2%

Total equity$1.6B+7.5%

Total assets$3.4B+5.3%

Cash flow

See full

Operating cash flow$266.2M+11.9%

CapEx$32.0M+6.5%

Free cash flow$234.3M+12.7%

Valuation

See full

Market cap$41.53B+3.7%

Enterprise value$41.9B+3.3%

P/E37.9×-2.7×

P/S9.3×-0.6×

Profitability

See full

Gross margin62.1%+0.8pp

Operating margin31.6%+2.5pp

Net margin24.6%+1.9pp

FCF margin24.4%+2.8pp

Returns & leverage

See full

Return on equity72.9%+13.6pp

Debt / equity0.4×-0.1×

Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Idexx Laboratories's other commercial liabilities?: Idexx Laboratories (IDXX) reported other commercial liabilities of $453.55M in Q1 2026.
How has Idexx Laboratories's other commercial liabilities changed year-over-year?: Idexx Laboratories's other commercial liabilities decreased by 7.6% year-over-year, from $490.69M to $453.55M.
What is the long-term trend for Idexx Laboratories's other commercial liabilities?: Over 5 years (2020 to 2025), Idexx Laboratories's other commercial liabilities has grown at a 5.0% compound annual growth rate (CAGR), from $415.65M to $530.15M.